A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, ...

I expected that becoming cancer-free would mean getting my old life back. Nothing could be further from the truth.

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

During a live event, Jahan Aghalar, MD, discussed the efficacy and safety of darolutamide plus ADT in mHSPC in the ARANOTE ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.